BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30389446)

  • 1. Differential Survival Characteristics of Sarcomatoid Subtype in Biphasic Pleural Mesothelioma.
    Harling L; Kolokotroni SM; Nair A; Smelt J; King J; Routledge T; Spicer J; Ng W; Bille A
    Ann Thorac Surg; 2019 Mar; 107(3):929-935. PubMed ID: 30389446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival results in biphasic malignant pleural mesothelioma patients: A multicentric analysis.
    Lococo F; Torricelli F; Lang-Lazdunski L; Veronesi G; Rena O; Paci M; Casadio C; Piana S; Novellis P; Di Stefano TS; Ciarrocchi A; Billè A
    J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1584-1593.e2. PubMed ID: 31590954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended pleurectomy decortication for malignant pleural mesothelioma in the elderly: the need for an inclusive yet selective approach.
    Sharkey AJ; Bilancia R; Tenconi S; Nakas A; Waller DA
    Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):696-702. PubMed ID: 29049744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early-stage Clinical Characterization of Malignant Pleural Mesothelioma.
    Negi Y; Kuribayashi K; Funaguchi N; Doi H; Mikami K; Minami T; Takuwa T; Yokoi T; Hasegawa S; Kijima T
    In Vivo; 2018; 32(5):1169-1174. PubMed ID: 30150440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleurectomy-decortication in malignant pleural mesothelioma: are different surgical techniques associated with different outcomes? Results from a multicentre study.
    Marulli G; Breda C; Fontana P; Ratto GB; Leoncini G; Alloisio M; Infante M; Luzzi L; Paladini P; Oliaro A; Ruffini E; Benvenuti MR; Pariscenti G; Spaggiari L; Casiraghi M; Rusca M; Carbognani P; Ampollini L; Facciolo F; Leuzzi G; Mucilli F; Camplese P; Romanello P; Perissinotto E; Rea F
    Eur J Cardiothorac Surg; 2017 Jul; 52(1):63-69. PubMed ID: 28419212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in malignant pleural mesothelioma: a retrospective study of 60 Turkish patients.
    Koyuncu A; Koksal D; Ozmen O; Demirag F; Bayiz H; Aydogdu K; Berkoglu M
    J Cancer Res Ther; 2015; 11(1):216-22. PubMed ID: 25879365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparities in Compliance With National Guidelines for the Treatment of Malignant Pleural Mesothelioma.
    Espinoza-Mercado F; Borgella JD; Berz D; Alban RF; Sarkissian A; Imai HTA; Soukiasian HJ
    Ann Thorac Surg; 2019 Sep; 108(3):889-896. PubMed ID: 31004585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is There a Role for Cancer-Directed Surgery in Early-Stage Sarcomatoid or Biphasic Mesothelioma?
    Kim S; Bull DA; Garland L; Khalpey Z; Stea B; Yi S; Hsu CC
    Ann Thorac Surg; 2019 Jan; 107(1):194-201. PubMed ID: 30278171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Trends in the Epidemiology of Malignant Pleural Mesothelioma: A National Cancer Data Base Study.
    Saddoughi SA; Abdelsattar ZM; Blackmon SH
    Ann Thorac Surg; 2018 Feb; 105(2):432-437. PubMed ID: 29223422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical Radiation Therapy After Lung-Sparing Surgery for Malignant Pleural Mesothelioma: Survival, Pattern of Failure, and Prognostic Factors.
    Minatel E; Trovo M; Bearz A; Di Maso M; Baresic T; Drigo A; Barresi L; Furlan C; Del Conte A; Bruschi G; Fontana P; Pagan V; Franchin G
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):606-13. PubMed ID: 26281826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma.
    Shaikh F; Zauderer MG; von Reibnitz D; Wu AJ; Yorke ED; Foster A; Shi W; Zhang Z; Adusumilli PS; Rosenzweig KE; Krug LM; Rusch VW; Rimner A
    J Thorac Oncol; 2017 Jun; 12(6):993-1000. PubMed ID: 28341225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: a 10-year experience.
    Lang-Lazdunski L; Bille A; Papa S; Marshall S; Lal R; Galeone C; Landau D; Steele J; Spicer J
    J Thorac Cardiovasc Surg; 2015 Feb; 149(2):558-65; discussion 565-6. PubMed ID: 25726878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Return to intended oncologic treatment after surgery for malignant pleural mesothelioma.
    Nelson DB; Rice DC; Mitchell KG; Tsao AS; Gomez DR; Sepesi B; Mehran RJ
    J Thorac Cardiovasc Surg; 2019 Sep; 158(3):924-929. PubMed ID: 31430846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended Pleurectomy-Decortication-Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years.
    Friedberg JS; Simone CB; Culligan MJ; Barsky AR; Doucette A; McNulty S; Hahn SM; Alley E; Sterman DH; Glatstein E; Cengel KA
    Ann Thorac Surg; 2017 Mar; 103(3):912-919. PubMed ID: 27825687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales.
    Linton A; Pavlakis N; O'Connell R; Soeberg M; Kao S; Clarke S; Vardy J; van Zandwijk N
    Br J Cancer; 2014 Oct; 111(9):1860-9. PubMed ID: 25188323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial.
    Lim E; Waller D; Lau K; Steele J; Pope A; Ali C; Bilancia R; Keni M; Popat S; O'Brien M; Tokaca N; Maskell N; Stadon L; Fennell D; Nelson L; Edwards J; Tenconi S; Socci L; Rintoul RC; Wood K; Stone A; Muthukumar D; Ingle C; Taylor P; Cove-Smith L; Califano R; Summers Y; Tasigiannopoulos Z; Bille A; Shah R; Fuller E; Macnair A; Shamash J; Mansy T; Milton R; Koh P; Ionescu AA; Treece S; Roy A; Middleton G; Kirk A; Harris RA; Ashton K; Warnes B; Bridgeman E; Joyce K; Mills N; Elliott D; Farrar N; Stokes E; Hughes V; Nicholson AG; Rogers CA;
    Lancet Respir Med; 2024 Jun; 12(6):457-466. PubMed ID: 38740044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological characteristics and prognosis of malignant pleural mesothelioma].
    Chen WH; Zhang XL; Dai HP; Tong ZH; Zhang YH; Jin ML
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Nov; 36(11):825-8. PubMed ID: 24507393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined modality treatment for malignant pleural mesothelioma: a single-centre long-term survival analysis using extrapleural pneumonectomy.
    Frick AE; Nackaerts K; Moons J; Lievens Y; Verbeken E; Lambrecht M; Coolen J; Dooms C; Vansteenkiste J; De Leyn P; Nafteux P
    Eur J Cardiothorac Surg; 2019 May; 55(5):934-941. PubMed ID: 30535191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does surgery improve survival of patients with malignant pleural mesothelioma?: a multicenter retrospective analysis of 1365 consecutive patients.
    Bovolato P; Casadio C; Billè A; Ardissone F; Santambrogio L; Ratto GB; Garofalo G; Bedini AV; Garassino M; Porcu L; Torri V; Pastorino U
    J Thorac Oncol; 2014 Mar; 9(3):390-6. PubMed ID: 24518090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of malignant pleural mesothelioma.
    Rodríguez Panadero F
    Arch Bronconeumol; 2015 Apr; 51(4):177-84. PubMed ID: 25059587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.